Health
DLnano-vaccines may be a promising strategy for cancer immunotherapy – News-Medical.Net
Researchers designed DLnano-vaccines displaying 60 copies of protein parts derived from the melanoma-specific antigens Trp2 and Gp100 and tested these in mouse models of melanoma, observing prolonged survival that depended on CD8 T cell activation both in the…
Reviewed by Emily Henderson, B.Sc.Sep 10 2020
Researchers designed DLnano-vaccines displaying 60 copies of protein parts derived from the melanoma-specific antigens Trp2 and Gp100 and tested these in mouse models of melanoma, observing prolonged survival that depended on CD8 T cell activation both in therapeutic and prophylactic settings.
One of the advantages of synthetic DNA technologies over other methods is the versatility of the platforms. DLnano-vaccines may be designed for various cance…
-
General19 hours agoFour charged over alleged six-hour gang rape of girl in south-west Sydney
-
Noosa News21 hours agoLogan City Council to pull out of federal government Climate Active program due to financial pressure, transparency concerns
-
Business23 hours agoAiming for rock-solid retirement income? I’d buy these two ASX shares
-
Noosa News18 hours agoCharlie the therapy dog reduces stress – Proctor